↓ Skip to main content

Practical Evidence-Based Recommendations for Patients with Multiple Sclerosis Who Want to Have Children

Overview of attention for article published in Neurology and Therapy, August 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
64 Mendeley
Title
Practical Evidence-Based Recommendations for Patients with Multiple Sclerosis Who Want to Have Children
Published in
Neurology and Therapy, August 2018
DOI 10.1007/s40120-018-0110-3
Pubmed ID
Authors

Yara Dadalti Fragoso, Tarso Adoni, Joseph B. Bidin Brooks, Alessandro Finkelsztejn, Paulo Diniz da Gama, Anderson K. Grzesiuk, Vanessa Daccach Marques, Monica Fiuza K. Parolin, Henry K. Sato, Daniel Lima Varela, Claudia Cristina F. Vasconcelos

Abstract

Multiple sclerosis (MS) management presently aims to reach a state of no (or minimal) evidence of disease activity. The development and commercialization of new drugs has led to a renewed interest in family planning, since patients with MS may face a future with reduced (or no) disease-related neurological disability. The advice of neurologists is often sought by patients who want to have children and need to know more about disease control at conception and during pregnancy and the puerperium. When MS is well controlled, the simple withdrawal of drugs for patients who intend to conceive is not an option. On the other hand, not all treatments presently recommended for MS are considered safe during conception, pregnancy and/or breastfeeding. The objective of the present study was to summarize the practical and evidence-based recommendations for family planning when our patients (women and men) have MS.Funding TEVA Pharmaceutical Brazil.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 64 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 16%
Student > Bachelor 8 13%
Other 8 13%
Student > Doctoral Student 5 8%
Researcher 5 8%
Other 8 13%
Unknown 20 31%
Readers by discipline Count As %
Medicine and Dentistry 12 19%
Psychology 8 13%
Neuroscience 7 11%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Nursing and Health Professions 4 6%
Other 7 11%
Unknown 21 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2020.
All research outputs
#12,812,167
of 23,102,082 outputs
Outputs from Neurology and Therapy
#181
of 424 outputs
Outputs of similar age
#153,490
of 334,790 outputs
Outputs of similar age from Neurology and Therapy
#5
of 8 outputs
Altmetric has tracked 23,102,082 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 424 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.3. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 334,790 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.